Of 160 000 molecules, the authors identified 1-[3-(2-chlorophenoxy)propyl]-1H-indole-3carbonitrile (CPIC) as a compound that was able to reduce AR-specific DNA binding, although it remains unclear whether this compound works directly by binding to the DBD 183
These organoids were treated with inflammatory stimuli (TNF, IFN, LPS), microbial structures (MDP, LPS), and an OXPHOS inhibitor (oligomycin) to assess the effects on GLP-1 secretion, EEC marker gene expression ( CHGA , TRIB3 ), and overall epithelial differentiation
This project was conceived by VV
We cover BPC-157 for disc and muscle healing, TB-500 for systemic inflammation reduction, GHK-Cu for tissue regeneration, and specialized compounds for nerve pain and spinal degeneration
Similarly, tirzepatide, a dual GLP-1/GIP receptor agonist, demonstrated impressive results in the SYNERGY-NASH trial, with a high percentage (74%) of participants achieving an absence of NASH and no worsening of fibrosis
Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression
